NCT02277964View on ClinicalTrials.gov

Disease Control in RRMS Transferring Treatment From Natalizumab to Fingolimod

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Relapsing Remitting Multiple Sclerosis
Trial Locations (1)

4031

University Hospital Basel, Switzerland, Basel

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER